Remove 2006 Remove Doctors Remove Sales
article thumbnail

Personal responsibility in the obesity epidemic

World of DTC Marketing

After a visit to his doctor, he found out that he had diabetes and was immediately put on medication. According to Euromonitor’s most recent data, Americans remain the world leaders when it comes to per capita sales of soft drinks. One of the guys I served with was having issues with nerve pain in his hands.

Food 207
article thumbnail

Capturing progress in haemophilia care

pharmaphorum

Lutz Bonacker joined CSL Behring in 2006 as Head of Global Commercial Development Coagulation and was promoted to his current position in 2015. He is responsible for the management of 14 European affiliates in the achievement of their sales goals and business objectives. About the author. References. Berntorp E., Haemophilia.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Big three distributors claim win in $2.5bn WV opioid case

pharmaphorum

He accepted the companies’ position that the painkillers they supplied – some 51 million between 2006 and 2014 – were shipped “in good faith” by the distributors before being prescribed by physicians and dispensed by pharmacies, and they had no way of telling whether those prescriptions were legitimate. .

Doctors 59
article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake. References.

article thumbnail

Comparison of Humira biosimilars in the US and Europe

Pharmaceutical Technology

Currently, 40 biosimilars are FDA-approved and 25 have launched, whereas the EMA has approved 86 biosimilars since 2006. In addition, insurers’ contracting practices can help preserve the sales of brand-name drugs. Patients may be reluctant to switch to biosimilars and doctors may have limited incentives to choose biosimilars.

article thumbnail

Biogen’s $900 million settlement signals scrutiny on speaker fees

Pharmaceutical Technology

In 2009, Tysabri was performing well, having yielded $776 million in sales after being first approved in 2004, as per Biogen’s 2009 financial filings. Some companies try to separate the clinical educational programs from their sales programs, and the speaker programs are run through the clinical education programs.

article thumbnail

Deep Career Insights And A Side Of Orthopedics With Eric Ford Part 1

Evolve Your Success

If you’re looking to get into a career in medical sales, this is the episode for you. That’s not only a big deal in the medical sales space. He is also the youngest sales director in Johnson & Johnson’s Vision Care. We get into what makes an amazing sales rep. That’s a big deal in the corporate world. I’m doing well.

Sales 52